SAFE-BioPharma is a global non-profit association that manages digital identity and digital signature industry standards. What began as a PhRMA initiative to encourage the use of common digital standards, has now become an independent body with the ability to impose standards upon both government and private industry.

The SAFE (Signatures and Authentication for Everyone) initiative created a digital identity standard for the signing of e-documents. The US Food and Drug Administration (FDA) agreed to accept digital signatures for electronic drug approval submissions to allow for efficiencies within the long and often drawn out drug approval processes.

SAASPASS considers and conforms with all SAFE-BioPharma rules and regulations. SAASPASS was built to adhere to the highest authentication requirements and regularly follows evolving international law.